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In response to cardiac damage, a mesothelial tissue layer enveloping the heart called the epicardium is activated to proliferate and accumulate at the injury site. Recent studies have implicated the epicardium in multiple aspects of cardiac repair: as a source of paracrine signals for cardiomyocyte survival or proliferation; a supply of perivascular cells and possibly other cell types such as cardiomyocytes; and as a mediator of inflammation [1] [2] [3] [4] [5] [6] [7] [8] [9] . However, the biology and dynamism of the adult epicardium is poorly understood. To investigate this, we created a transgenic line to ablate the epicardial cell population in adult zebrafish. Here we find that genetic depletion of the epicardium after myocardial loss inhibits cardiomyocyte proliferation and delays muscle regeneration. The epicardium vigorously regenerates after its ablation, through proliferation and migration of spared epicardial cells as a sheet to cover the exposed ventricular surface in a wave from the chamber base towards its apex. By reconstituting epicardial regeneration ex vivo, we show that extirpation of the bulbous arteriosus-a distinct, smooth-muscle-rich tissue structure that distributes outflow from the ventricle-prevents epicardial regeneration. Conversely, experimental repositioning of the bulbous arteriosus by tissue recombination initiates epicardial regeneration and can govern its direction. Hedgehog (Hh) ligand is expressed in the bulbous arteriosus, and treatment with a Hh signalling antagonist arrests epicardial regeneration and blunts the epicardial response to muscle injury. Transplantation of Sonic hedgehog (Shh)-soaked beads at the ventricular base stimulates epicardial regeneration after bulbous arteriosus removal, indicating that Hh signalling can substitute for the influence of the outflow tract. Thus, the ventricular epicardium has pronounced regenerative capacity, regulated by the neighbouring cardiac outflow tract and Hh signalling. These findings extend our understanding of tissue interactions during regeneration and have implications for mobilizing epicardial cells for therapeutic heart repair.
To assess the homeostatic properties of the epicardium, we used an inducible cell ablation system in adult zebrafish. Targeted expression of bacterial nitroreductase (NTR) depletes specific cell types via conversion of a non-toxic substrate, metronidazole (Mtz), to a cytotoxin [10] [11] [12] . We used tcf21 regulatory sequences, which in zebrafish drive the most widespread epicardial expression of known DNA elements 2 , to create an NTR transgenic line for lesioning this tissue without direct myocardial damage. After treatment of adult tcf21:NTR; tcf21:nuceGFP animals with Mtz, ,90% of enhanced green fluorescent protein (eGFP) 1 epicardial nuclei on average were ablated from the ventricular surface in large patches (Fig. 1a, b, f) .
To determine whether epicardial depletion affects the well-documented capacity of the zebrafish heart to regenerate 13 , we transiently incubated tcf21:NTR zebrafish with Mtz after resection of the ventricular apex. Mtz treatment reduced epicardial cell number in the 7 days post-amputation (dpa) injury site by ,45%, while reducing cardiomyocyte proliferation indices by ,33% (Fig. 1c, d and Extended Data Figs 1a, b, 3c). Myofibroblasts were represented similarly in vehicle-and Mtz-treated clutchmates by 14 dpa (Extended Data  Fig. 1c ). Injured ventricles of Mtz-treated animals displayed reduced vascularization and muscularization by 30 dpa (Fig. 1e and Extended Data Fig. 1d , e), associated with fibrin and collagen retention (Fig. 1e) . By 60 dpa, ventricles from Mtz-treated zebrafish consistently showed normal muscularization and a large complement of tcf21:nuceGFP 1 cells, along with minor collagen deposits (Extended Data Fig. 1f) . Thus, depletion of epicardial tissue inhibits cardiomyocyte proliferation and vascularization after resection injury, reducing the efficacy of heart regeneration.
These experiments suggested a high capacity of epicardial cells to regenerate after major depletion. To test this directly, we examined otherwise uninjured hearts at different times after epicardial ablation. Ventricular epicardial cells typically have a low proliferation index (Extended Data Fig. 2a ). However, within 3 days of Mtz treatment (3 days post-incubation (dpi)), many spared epicardial cells entered the cell cycle (Extended Data Fig. 2b, c) . At 7 dpi, ventricles displayed quantifiable epicardial recovery that was more prominent at the chamber base (Fig. 1b) . By 14 dpi, and as early as 7 dpi, ventricles were fully covered to their apices with tcf21:nuceGFP 1 epicardial cells (Fig. 1b, f) . The temporal variation in recovery probably reflects variation in the location/pattern of epicardial cells spared by ablation among clutchmates, or in chamber size (Extended Data Fig. 3a) . To examine the origins of the regenerated epicardium, we used inducible Cre-based genetic fate-mapping to label tcf21-expressing cells and their progeny permanently before injury 2 . Labelling and subsequent fate-mapping experiments indicated that pre-existing epicardial cells, and not a tcf21-negative precursor, are a primary source for regeneration (Fig. 1g, h ). In sum, these experiments reveal that adult epicardium regenerates after substantial genetic ablation, through a mechanism of expansion by spared epicardial cells.
To expand our range of experimental manipulations, we refined protocols such that freshly dissected hearts contracted for several weeks ex vivo (Supplementary Video 1) 14, 15 . When Mtz was added transiently to the culture medium for 1 day, ventricular epicardial cells were potently ablated. Epicardial layers of the atrium and the bulbous arteriosus (alternatively referred to as the outflow tract) were less effectively depleted (Fig. 2a) , probably owing to differential expression of the NTR transgene among cardiac chambers (Extended Data  Fig. 3b ). Daily imaging of these hearts confirmed observations from in vivo experiments, demonstrating regeneration of the epicardium from base to apex that was typically completed in 2 weeks (Fig. 2a) . Hearts from animals given partial ventricular resections in vivo showed a similar pattern of epicardial regeneration after ex vivo ablation (Extended Data Fig. 4a ). Cardiac muscle regeneration was ineffective in explanted hearts in our experiments. Increases in cell number occurred concomitantly with movement across the myocardial surface during epicardial regeneration, with spared epicardial cell patches away from the leading edge eventually incorporated into the sheet (Fig. 2a) .
To identify possible intrinsic differences in epicardial cells from different ventricular regions, we examined behaviours of basal or apical epicardial tissue patches transplanted to ablated ventricles. In these experiments, transplanted cells of either origin consistently repopulated the ventricular surface in a base-to-apex direction after transplantation (Extended Data Fig. 5a-d) , revealing no proliferative bias in ventricular epicardial cells that could explain the directional flow of regeneration. To assess potential extrinsic influences on epicardial regeneration, we removed the atrium or bulbous arteriosus from its attachment at the ventricular base before epicardial ablation. Atrial extirpation did not noticeably affect the regeneration of ventricular epicardium ( Fig. 2b and Supplementary Video 2). By contrast, removal of outflow tract tissue blocked epicardial cell recovery, an arrest that persisted for at least 2 weeks (Fig. 2c, d and data not shown). To test whether this arrest was solely a consequence of mechanical tissue disruption, we ablated the epicardium after host bulbous arteriosus removal, before grafting a non-transgenic bulbous arteriosus to the ventricular base 2 days later. In most of these tissue recombination procedures (13 of 21), host tcf21:nuceGFP 1 epicardium regenerated to cover the ventricle (Fig. 3a) . This effect was not observed when a portion of donor ventricular apex was inverted and transplanted to the host ventricular base (Extended Data Fig. 5e ). Complementary grafting experiments indicated that bulbous arteriosus could contribute epicardial cells to the ventricular surface, as a potential supplement to expansion of the ventricular epicardial cell pool (Extended Data Fig. 5f ). Thus, our experiments indicate that outflow tract tissue provides an essential interaction for regeneration from existing ventricular epicardial cells.
To test whether outflow tract tissue is sufficient to stimulate epicardial regeneration, we ectopically positioned experimentally manipulated cardiac structures. Co-culture of several outflow tracts in a transwell assay with an epicardially ablated ventricle did not restore regeneration in the absence of host bulbous arteriosus (Extended Data  Fig. 6a ). Similarly, a bulbous arteriosus graft placed at the ventricular apex showed no evidence of directing regeneration of basally located host epicardial cells towards the apex (Extended Data Fig. 6b ). Thus, we could not detect bulbous arteriosus effects requiring long-range diffusion through tissue or culture medium. Next, we transplanted a tcf21:nuceGFP 1 epicardial cell patch to the apex of an ablated host ventricle, after which we grafted a wild-type bulbous arteriosus to the 1 cells from experiments in g. ***P , 0.001, Student's two-tailed t-test; n 5 10 (vehicle, 3 dpi), 13 (Mtz, 3 dpi) and 15 (Mtz, 14 dpi). c, g, Insets, high magnifications of boxed areas. Scale bars, 50 mm. Error bars indicate standard deviation (s.d.).
LETTER RESEARCH apex (Fig. 3b) . Remarkably, the apical bulbous arteriosus was capable of stimulating apex-to-base regeneration from the nearby epicardial patch in a high proportion (21 of 32) of experiments, effectively reversing the stereotypical direction of recovery (Fig. 3c, d ). Together, these experiments indicate that the cardiac outflow tract is necessary and sufficient for epicardial regeneration, and that this neighbouring tissue provides a short-range influence(s) that directs regeneration from base to apex.
To pursue the molecular nature of interactions between outflow tract and ventricular epicardium, we applied a small panel of signalling pathway effectors to epicardially ablated hearts cultured ex vivo. Among several compounds (Extended Data Fig. 7 ), the Smoothened (Smo) antagonist cyclopamine (CyA) blocked regeneration; nonetheless, regeneration initiated normally after drug washout (Fig. 4a) . CyA treatment reduced spontaneous epicardial cell 5-ethynyl-29-deoxyuridine (EdU) incorporation occurring in the first 2 days of explant culture, suggesting that intact Hh signalling promotes epicardial proliferation (Extended Data Fig. 8a, b) . CyA also disrupted in vivo epicardial regeneration, not only in adults but in larvae, an additional developmental setting in which we identified base-to-apex regeneration (Fig. 4b, c and Extended Data Fig. 9a-c) . CyA treatment from 2 to 4 days post-fertilization also reduced the initial epicardial occupancy of the larval ventricle (Extended Data Fig. 9d-f ), indicating that epicardial regeneration recapitulates at least one pathway influential in morphogenesis. Finally, we observed inhibitory effects of CyA on the epicardial proliferative response to muscle resection in vivo, and in coverage of these injuries ex vivo (Extended Data Fig. 4b and Extended Data Fig. 8c, d ).
Smo is an effector for several Hh family ligands, which have potent short-range effects in multiple contexts of embryonic development [16] [17] [18] [19] [20] [21] . Quantitative polymerase chain reaction (qPCR) revealed shha, ihhb and dhh ligand transcripts in adult atrium, ventricle and bulbous arteriosus, where in situ hybridization detected shha and dhh transcript signals in smooth muscle tissue (Extended Data Fig. 10a-d ). Epicardial ablation injury boosted bulbous arteriosus and ventricular shha levels, as well as levels of ptch1 and gli2a in purified epicardial cells (Fig. 4d, e) . Moreover, a shha:eGFP reporter strain visualized shha regulatorysequence-driven fluorescence in smooth muscle and epicardial tissues of the bulbous arteriosus (Extended Data Fig. 10e ). No additional in situ hybridization or shha:eGFP fluorescence patterns were detectable after epicardial ablation; however, apical resection injury induced fluorescence in ventricular epicardial tissue by 2 dpa (Extended Data  Fig. 10d, f) . To test whether local Hh ligand delivery is sufficient to substitute for the bulbous arteriosus, we removed atrium and bulbous arteriosus from cardiac explants, ablated epicardial cells, and applied 
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beads soaked with Shh protein to the exposed ventricular base. Shhsoaked beads stimulated epicardial regeneration (one-half or greater coverage) in 9 of 32 ventricles, whereas this level of recovery never occurred after transplantation of BSA-soaked beads (0 of 27 ventricles; Fig. 4f ). We speculate that these effects of Hh on the epicardial sheet might involve cytoplasmic extensions or a factor transport system 22, 23 . Together, our findings support a model in which Hh ligand from the outflow tract, and possibly additional tissues, guides the base-to-apex regeneration of ventricular epicardium.
In conclusion, we have identified a requirement for the mesothelial covering of the zebrafish heart for proficient muscle regeneration. Moreover, we show that the ventricular epicardium itself has high endogenous renewal capacity, vigorously regenerating as a sheet from the base of the chamber to its apex after genetic depletion. Our results point to the outflow tract as an unexpected signalling centre and source of Hh, and possibly additional influences, that can promote epicardial regeneration. It is likely that tissue regeneration is similarly regulated in trans in other contexts; for example, to maintain the mesothelium that lines abdominal organs. As a mediator of epicardial regeneration, Hh signalling can be integrated into new strategies to modulate repair of the damaged heart.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
METHODS
Zebrafish maintenance and procedures. Adult zebrafish of the Ekkwill and Ekkwill/AB strains were maintained as described and resection injuries were performed as described 13, 24 . Animals between 4 and 12 months of both sexes were used. Transgenic lines used in this study were Tg(tcf21:mCherry-NTR) 12 . If ablation was performed after ventricular resection, we used a protocol of daily changes of 1 mM Mtz solution for 3 days that had similar ablation effects (Extended Data  Fig. 3c ). This period corresponds with the early epicardial proliferative response to resection injury 7 (data not shown), and was intended to extend the ablation window and improve animal survival. For larval epicardial ablation, 6 hours postfertilization (hpf) embryos were bathed for 48 h in 10 mM Mtz before washout. For ex vivo epicardial ablation, dissected hearts were bathed for 24 h in 1 mM Mtz before washout. Cyclopamine (CyA; Selleckchem) was dissolved in ethanol to a final concentration of 20 mM. CyA was used at 10 mM for in vivo treatment of adult animals and 5 mM for ex vivo culture and embryo treatments. For EdU incorporation experiments that followed epicardial ablation, animals were injected with 10 mM EdU 4 h before collection. Experiments with uninjured animals used three daily 10 mM EdU injections. For lineage tracing, strains carrying tcf21:NTR; tcf21:CreER and gata5:loxp-mCherry-loxp-nuceGFP transgenes were placed in a small beaker of aquarium water containing 5 mM tamoxifen. Fish were maintained for 24 h, rinsed with fresh aquarium water, and returned to a recirculating aquatic system for 24 h, before repeating this incubation twice. After 3 days of rinsing, Mtz was added for an additional 24 h. As is common when using Cre-based tools, we could not genetically label all epicardial cells in these experiments or rule out minor contributions by tcf21-negative cells. Animal procedures were performed in accordance with Duke University guidelines. Construction of tcf21:NTR zebrafish. The translational start codon of tcf21 in the bacterial artificial chromosome (BAC) clone DKEYP-79F12 was replaced with the mCherry-NTR cassette by Red/ET recombineering technology (Gene Bridges) 12 . The 59 and 39 homologous arms for recombination were a 50-base pair (bp) fragment upstream and downstream of the start codon, and were included in PCR primers to flank the mCherry-NTR cassette. To avoid aberrant recombination between the mCherry-NTR cassette and the endogenous loxP site in the BAC vector, we replaced the vector-derived loxP site with an I-SceI site using the same technology. The final BAC was purified with Nucleobond BAC 100 kit (Clontech) and co-injected with I-SceI into one-cell-stage zebrafish embryos. Ex vivo cardiac explants. Adult hearts were rinsed several times in PBS after collection and cultured in dishes with DMEM medium (Life Technologies) plus 2 mM L-glutamine (Life Technologies), 10% fetal bovine serum (HyClone, Thermo), 1% MEM non-essential amino acids (Life Technologies), 100 U ml 21 penicillin, 100 mg ml 21 streptomycin (Life Technologies) and 50 mM 2-mercaptoethanol (Life Technologies), while rotating at 150 r.p.m. Primocin (InvivoGen) was added to prohibit microbial contaminants during the first 3 days primary culture. For transplantation experiments, outflow tract or ventricular tissues were grafted by mounting in 1% low-melting-point agarose with ablated hearts in culture dishes, and covering with medium. After 2 days of culturing, attached tissues were released from the agarose; if transplanting an epicardial patch, the ventricular donor tissue was removed carefully using forceps. Fluorescent transgenes in these cardiac explants were monitored using a Leica MZ05FA stereofluorescence microscope.
Recombinant mouse Shh (C25II), N terminus protein (R & D Systems) was reconstituted at 100 mg ml 21 in PBS containing 0.1% BSA. Affi-Gel Blue beads (Bio-Rad) were prepared by thoroughly washing the beads in PBS, then incubating them in the Shh solution for 2 h at room temperature. A solution with the same concentration of BSA protein was used as the control. The beads were then applied to the base of ventricular explants that were settled in low-melting-point agarose in serum-free DMEM supplemented as described earlier. After 24 h, the ventricles were released from the agarose with the attached beads and cultured in supplemented, serum-free DMEM. Under these ex vivo culture conditions we observed no increase in cardiomyocyte proliferation upon resection injury. Preparation of outflow tract and ventricular epicardial cells and RT-qPCR. Adult hearts were dissected from tcf21:NTR or tcf21:NTR; tcf21:nuceGFP animals 3 and 7 days post-treatment with vehicle or Mtz. Outflow tracts were frozen in liquid nitrogen. Ventricular nuceGFP 1 epicardial cells were isolated as described previously 28 with modifications. Briefly, ventricles were collected on ice and washed several times to remove blood cells. Ventricles were digested in an Eppendorf tube with 0.5 ml HBSS plus 0.13 U ml 21 Liberase DH (Roche) and 1% sheep serum at 37 uC, while stirring gently with a Spinbar magnetic stirring bar (Bel-Art Products). Supernatants were collected every 5 min and neutralized with sheep serum. Dissociated cells were spun down and sorted using a BD FACSVantage SE sorter for eGFP-positive cells. Total RNA was extracted using an RNAqueous-Micro isolation kit (Ambion) according to the manufacturer's instructions. Reverse transcription was carried out using a SuperScript III FirstStrand synthesis kit (Life Technologies). qPCR was carried out in triplicate using a Roche LightCycler 480 II system with the LightCycler 480 Probes Master Mix and the Universal Probe Library (UPL) (Roche). rpl13a served as the control. Primers and the UPL numbers used in this study were: shha-f, AAGCCCACATTCAT TGCTCT, and shha-r, CCTTCTGTCCTCCGTCCTG, UPL #54; shhb-f, GCAAG TATGGGATGCTATCCAG, and shhb-r, TCCTGATTTAGCAGCCACTG, UPL #16; ihha-f, TGGGTCTACTATGAGTCCAAAGC, and ihha-r, GGTTTTAGCA GCCACAGAGTG, UPL #86; ihhb-f, TCTTGTTATGCTGCGGTGAA, and ihhb-r, AAGCGTAGAGGTGCAAAAGC, UPL #140; dhh-f, CGTGCACTGCTCTGT CAAA, and dhh-r, AAACATGACATGGGCTTTTGT, UPL #156; ptch1-f, TG GCTTAAGGGCAGCTAATC, and ptch1-r, GCCGTGTGTACTTGAGTTCCT, UPL #87; ptch2-f, CCATGACATCAACTGGAATGA, and ptch2-r, GAATGCT CCCATGAACAACC, UPL #6; gli1-f, CTGCAGCAAAGAGTTCGACA, and gli1-r, CTCCGTGGATGTGCTCATTA, UPL #68; gli2a-f, CCTCACCCACC ACAGCAT, and gli2a-r, CGATCGGGATTGGTGTGT, UPL #39; gli2b-f, CCTGCCAGAATACTTCACATCA, and gli2b-r, CTCAACCTGGGCGTCA TAC, UPL #48; rpl13a-f, GCGGACCGATTCAATAAGG, and rpl13a-r, GAAAGACGACCGAGGAGATG, UPL #147. Histology. Analyses of cardiomyocyte proliferation were performed as previously described by counting Mef2 1 and PCNA 1 nuclei in wound sites 14 .
To quantify vascular endothelial cells in the wound site by 30 dpa with fli1a:eGFP or tcf21NTR; fli1a:eGFP animals, three medial, longitudinal sections were selected from each heart. Images of single optical slices of green fluorescence in the wound site were acquired using a 320 objective (1,024 3 1,024 pixels). eGFP 1 areas were quantified in pixels by ImageJ software, and the ratio of eGFP 1 area versus the length of the outlined apical wound was calculated for each heart. To quantify tcf21 1 epicardial cells in the wound site at 7 and 30 dpa with tcf21:nuceGFP or tcf21:NTR; tcf21:nuceGFP animals, three medial, longitudinal sections were selected from each heart. eGFP 1 cells were counted in the wound area, and the ratio of eGFP 1 cells versus the length of the outlined apical wound was calculated for each heart. Acid Fuchsin-Orange G and immunostaining were performed as described 13 . Primary antibodies used in this study were anti-myosin heavy chain (MHC; F59, mouse; Developmental Studies Hybridoma Bank), anti-GFP (rabbit; Invitrogen), anti-Mef2 (rabbit; Santa Cruz Biotechnology), anti-MLCK (mouse, K36; Sigma) and anti-PCNA (mouse; Sigma). Secondary antibodies (Invitrogen) used in this study were: Alexa Fluor 488 goat anti-rabbit; Alexa Fluor 594 goat antirabbit, goat anti-rat and goat anti-mouse; and Alexa 633 goat anti-mouse. EdU was detected through a click reaction as described previously 29 with fluorescent azide (Alexa Fluor 594 or 647; Invitrogen). Whole-mounted and sectioned ventricular tissues were imaged used a Zeiss 700 confocal microscope. Data collection and statistics. Clutchmates (or hearts collected from clutchmates) were randomized into different treatment groups for each experiment. No animal or sample was excluded from the analysis unless the animal died during the procedure. All experiments were performed with at least two biological replicates, using appropriate numbers of samples for each replicate. Sample sizes were chosen on the basis of previous publications and experiment types, and are indicated in each figure legend. For expression patterns, at least six fish were examined. For assessment of epicardial ablation and consequences on muscle regeneration, at least nine fish were examined. At least 12 hearts of each group were pooled for RNA purification and subsequent RT-qPCR. For ex vivo epicardial ablation experiments, at least six hearts were used for each treatment. An exception was the small compound screen, where at least four hearts were used for each drug. Quantification of cell proliferation and calculation of statistical outcomes were assessed by a person blinded to the treatments. All statistical values are displayed as mean 6 standard deviation. Sample sizes, statistical tests, and P values are indicated in the figures or the legends. Student's t-tests (two-tailed) were applied when normality and equal variance tests were passed. The Mann-Whitney rank sum test was used when these failed. Fisher Irwin exact tests or chi-squared tests were used where appropriate. 
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Extended Data Figure 1 | Epicardial ablation and responses to resection injury. a, tcf21:nuceGFP or tcf21:NTR; tcf21:nuceGFP clutchmates underwent resection injury and were treated for 3 days with 1 mM Mtz, before collection of ventricles at 7 (n 5 8 animals per group) and 30 dpa (n 5 11). tcf21:NTR; tcf21:nuceGFP wounds had fewer epicardial cells at 7 dpa and comparable occupancy by 30 dpa compared with tcf21:nuceGFP wounds. White dashed lines indicate wound edge. b, Quantification of eGFP 1 epicardial cells at 7 and 30 dpa with respect to wound edge lengths from a. NS, not significant; MannWhitney rank sum test. c, tcf21:NTR clutchmates underwent resection injury and were treated for 3 days with 1 mM Mtz or vehicle with random separation into two groups for treatment. MLCK 1 cells, indicating myofibroblasts, had comparable presence in both groups at 14 dpa (n 5 7 for each group). ventricle. By contrast, NTR (red, indicated by mCherry) expression is patchy and/or weak in the atrium and outflow tract compared with ventricular expression. c, Section images of ventricles from tcf21:nuceGFP (left) or tcf21:NTR; tcf21:nuceGFP zebrafish (right) treated with 1 mM Mtz (right) for 3 days, and collected 2 days later. Ventricular epicardium was ablated effectively in these experiments. Scale bars, 50 mm.
resection. a, Hearts were removed from tcf21:NTR; tcf21:nuceGFP fish immediately after ventricular resection injuries, followed by 24 h of Mtz and a 24 h washout ex vivo. A base-to-apex pattern of epicardial regeneration was observed, in this example covering the apical wound by 11 dpa (n 5 18; behaviour seen in all samples). Epicardial coverage of resection injuries in these ablation experiments is delayed compared to ventricles recovering with an intact epicardium (b, top). Yellow boxed area, magnified view of the apical wound. Red dashed lines delineate ventricle. b, Hearts were removed from tcf21:nuceGFP clutchmates immediately after apical resection injury and cultured ex vivo, before random separation into two treatment groups. Epicardial cells covered the wound area by 3 dpa (n 5 11; behaviour seen in all samples), unless treated with CyA (n 5 26; failed coverage in 20 of 26 ventricles). a, b, White dashed lines indicate apical wounds. Scale bars, 50 mm.
a, Schematic of the experimental design. b, c, Epicardial cells transplanted at the base of an epicardially ablated host regenerated towards the apex regardless of basal (b) (n 5 25, behaviour seen in all samples) or apical (c) (n 5 27, all samples) origin. d, Top, epicardial cells from the base of a transgenic donor ventricle were transplanted to the chamber midpoint of an epicardially ablated host ventricle and observed for regeneration. Bottom, transplanted cells eventually migrated towards the apex, not the base (n 5 13; all samples). e, Top, after epicardial ablation, the host bulbous arteriosus was replaced with a nontransgenic donor ventricular apex and observed for regeneration. Bottom, ventricular epicardium showed little or no regeneration in these experiments (n 5 7; behaviour seen in all samples). f, Left, after ex vivo epicardial ablation in a host tcf21:NTR ventricle, the host bulbous arteriosus was replaced with a donor tcf21:nuceGFP bulbous arteriosus. Right, the host ventricular surface contained different amounts of eGFP 1 nuclei in these ventricles (n 5 3; behaviour seen in all samples). b-f, Red dashed lines indicate epicardium or epicardial leading edge; white dashed lines delineate ventricle. e, f, Yellow dashed lines indicate donor apex (e) or bulbous arteriosus (f). Scale bars, 50 mm.
Extended Data Figure 6 | Context-specific effects of outflow tract on epicardial regeneration. a, Top, after ex vivo epicardial ablation and bulbous arteriosus removal, ventricles were co-cultured with ten outflow tracts in a transwell assay and observed for regeneration. Bottom, no evidence for epicardial regeneration was observed in these experiments (n 5 9; behaviour seen in all samples). b, Left, after ex vivo epicardial ablation and bulbous arteriosus removal, a non-transgenic bulbous arteriosus (labelled as donor OFT) was transplanted to the apex and observed for regeneration. Right, no evidence for regeneration of eGFP 1 epicardium from apex to base was observed in these experiments (n 5 10; behaviour seen in all samples). Red dashed lines delineate epicardium; white dashed lines delineate ventricle; yellow dashed lines delineate donor outflow tract. Scale bars, 50 mm.
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Extended Data Figure 7 | Small-scale screen for compounds that inhibit epicardial regeneration. Ex vivo ablation and regeneration of tcf21:NTR; tcf21:nuceGFP ventricles over 7 days. Mtz was added for 24 h to freshly isolated hearts, washed out, and compounds were added after 2 days (day 0). Hearts were treated with vehicle (n . 10), 10 mM DEAB (n 5 5; Sigma-Aldrich), 100 nM LDN193189 (n 5 4; Cayman Chemical), 10 mM SU5402 (n 5 5; Santa Cruz Biotechnology), 1 mM cyclosporin A (n 5 4; Sigma-Aldrich), or 0.1 mg ml 
EdU
1 nuclei per mm 2 on the ventricular surface, from hearts in a. **P , 0.01, Student's two-tailed t-test. c, tcf21:nuceGFP adult fish were subjected to partial ventricular resection surgery, and randomly separated into two groups for treatment with vehicle (n 5 8) or 10 mM CyA (n 5 10) from 2 to 3 dpa. Then, 10 mM EdU was injected intraperitoneally 1 h before collection. 
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Extended Data Figure 9 | Larval epicardial development and regeneration. a, tcf21:nuceGFP or tcf21:NTR; tcf21:nuceGFP larval clutchmates were treated with 10 mM Mtz from 6 hpf to 54 hpf, and then imaged at different times from 3 to 5 dpf. tcf21:nuceGFP larvae show normal ventricular epicardial coverage at 3 dpf, while tcf21:NTR; tcf21:nuceGFP coverage is sparse. tcf21:NTR; tcf21:nuceGFP larvae with confirmed full ablation were imaged from 3 to 5 dpf, covering first the ventricular base and then the apex. Three different extents of regeneration at 5 dpf are shown: class I, greater than two-thirds coverage; class II, one-third to two-thirds coverage; and class III, some cells but less than onethird coverage. b, A subset of tcf21:NTR; tcf21:nuceGFP larvae with confirmed full ablations were randomly separated and treated with vehicle or CyA, which limited regeneration in most cases (class IV, no ventricular epicardial cells).
c, Quantification of extents of regeneration from experiments in a and b. ***P , 0.001, chi-squared test; n 5 54 embryos for vehicle, 51 for CyA. d, Epicardial morphogenesis visualized in tcf21:nuceGFP larvae. No epicardial cells are evident at or before 2 dpf. By 3 dpf, ventricles contained 17.6 6 6 epicardial cells on average (n 5 23), whereas 4 dpf larvae contained 45.2 6 5.8 cells (n 5 21). e, tcf21:nuceGFP larval clutchmates were randomly separated into two groups for treatment with vehicle or 5 mM CyA from 2 to 4 dpf. f, Quantification of ventricular eGFP 1 epicardial cells from groups in e. ***P , 0.001, Student's two-tailed t-test; n 5 21 for each group. LETTER RESEARCH
